At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 12 enrolled
Drug / intervention
Testosterone enanthate auto-injectorcombination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label Study to Evaluate the Pharmacokinetics of Testosterone Enanthate After Single-Dose Injection Via QuickShot® Testosterone in Healthy Male Subjects
In Brief
A Phase 1 clinical trial evaluating Testosterone enanthate auto-injector for Hypogonadism. Completed, enrolled 12 participants across 1 site.
Detailed Summary
Evaluation of pharmacokinetics of subcutaneous testosterone enanthate
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypogonadism
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartSep 2014
First PostedSep 2014
Primary CompletionOct 2014
TodayJul 2026
First PostedSep 8, 2014
Enrollment StartSep 1, 2014
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11.8 years ago
Interventions
Testosterone enanthate auto-injectorcombination
Randomization then administration of combination product study medication according to group assignment